Literature DB >> 26781167

Challenges in oral drug delivery in patients with esophageal dysphagia.

Wouter F W Kappelle1, Peter D Siersema1, Auke Bogte1, Frank P Vleggaar1.   

Abstract

INTRODUCTION: Esophageal dysphagia is a commonly reported symptom with various benign and malignant causes. Esophageal dysphagia can impede intake of oral medication, which often poses a major challenge for both patients and physicians. The best way to address this challenge depends of the cause of dysphagia. AREAS COVERED: The pathophysiology of esophageal dysphagia is discussed, diagnostic tools to determine its cause are reviewed and recent developments in the treatment of esophageal dysphagia are discussed. Alternative options to administer medication in dysphagia are discussed and the appropriateness of them reviewed. EXPERT OPINION: Two ways can be followed to allow medication intake in patients with esophageal dysphagia, i.e. altering medication or resolving dysphagia. The latter is generally preferred, since esophageal dysphagia rarely only impedes medication intake. Esophageal resection is possible in more advanced esophageal cancer stages due to advances in neo-adjuvant therapy. Due to recent improvements in intraluminal radiotherapy, it can be expected that this will be the primary treatment in a palliative setting. Temporary self-expandable metal stent placement is a promising new alternative for bougienage in difficult-to-treat benign strictures.

Entities:  

Keywords:  Dilation; Drug delivery; Endoscopy; Enteral feeding tube; Esophagus; Stent placement; esophageal dysphagia

Mesh:

Year:  2016        PMID: 26781167     DOI: 10.1517/17425247.2016.1142971

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  5 in total

Review 1.  Options for Treating Pain in Cancer Patients with Dysphagia.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

2.  Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil.

Authors:  Lupe Carolina Espinoza; Marcelle Silva-Abreu; Beatriz Clares; María José Rodríguez-Lagunas; Lyda Halbaut; María-Alexandra Cañas; Ana Cristina Calpena
Journal:  Pharmaceutics       Date:  2019-02-01       Impact factor: 6.321

3.  Validation of the PILL-5: A 5-Item Patient Reported Outcome Measure for Pill Dysphagia.

Authors:  Nogah Nativ-Zeltzer; Ahmed Bayoumi; Van Pierre Mandin; Matthew Kaufman; Indulaxmi Seeni; Maggie A Kuhn; Peter C Belafsky
Journal:  Front Surg       Date:  2019-07-24

4.  A Difficult Pill to Swallow: An Investigation of the Factors Associated with Medication Swallowing Difficulties.

Authors:  Chandramouli Radhakrishnan; Aida Sefidani Forough; Julie A Y Cichero; Heather E Smyth; Aisha Raidhan; Lisa M Nissen; Kathryn J Steadman
Journal:  Patient Prefer Adherence       Date:  2021-01-11       Impact factor: 2.711

5.  Pharmacokinetic similarity demonstrated after crushing of the elbasvir/grazoprevir fixed-dose combination tablet for HCV infection.

Authors:  Daniëlle W M Pijnenburg; Minou van Seyen; Evertine J Abbink; Angela Colbers; Joost P H Drenth; David M Burger
Journal:  J Antimicrob Chemother       Date:  2020-09-01       Impact factor: 5.758

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.